A common class of drugs called anticholinergics might boost risks for heart failure and other dangerous cardiac conditions, a new study says. People taking the largest amounts of anticholinergic drugs ...
A class of medications best known for treating diabetes and obesity may also reduce the risk of addiction—and help people who already have one, a new study shows.
Absci Corporation (ABSI) is working on developing the use of its biological drug ABS-101 for the treatment of patients with inflammatory bowel disease [IBD]. This drug is already de-risked in the fact ...
Imagine reaching for your daily medication, only to learn it could be putting your health at risk. That's the reality facing thousands of Americans after Teva Pharmaceuticals and Amerisource Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results